NCT00370747View on ClinicalTrials.gov

Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Dry Eye Syndromes
Interventions
DRUG

Ecabet

ophthalmic solution 2.83%

DRUG

Ecabet

ophthalmic solution 3.70%

DRUG

Placebo

Trial Locations (1)

92618

Irvine

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00370747 - Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome | Biotech Hunter | Biotech Hunter